ArticleFrontiers in neurology2020

Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke.

Changjun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.